Arcus Biosciences, Inc. (RCUS)
NYSE: RCUS · Real-Time Price · USD
25.45
+0.19 (0.75%)
At close: Dec 5, 2025, 4:00 PM EST
25.97
+0.52 (2.04%)
After-hours: Dec 5, 2025, 7:54 PM EST
Arcus Biosciences Stock Forecast
Stock Price Forecast
According to 8 professional analysts, the 12-month price target for Arcus Biosciences stock ranges from a low of $14 to a high of $56. The average analyst price target of $28.88 forecasts a 13.48% increase in the stock price over the next year.
Price Target: $28.88 (+13.48%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Arcus Biosciences stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 1 | 1 | 3 | 3 | 3 |
| Buy | 6 | 5 | 5 | 3 | 3 | 3 |
| Hold | 2 | 2 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 11 | 8 | 8 | 8 | 8 | 8 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| B of A Securities | B of A Securities | Hold Maintains $17 → $26 | Hold | Maintains | $17 → $26 | +2.16% | Nov 28, 2025 |
| Goldman Sachs | Goldman Sachs | Hold Maintains $14 → $16 | Hold | Maintains | $14 → $16 | -37.13% | Oct 30, 2025 |
| Citigroup | Citigroup | Strong Buy Maintains $54 → $56 | Strong Buy | Maintains | $54 → $56 | +120.04% | Oct 29, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $24 → $28 | Strong Buy | Maintains | $24 → $28 | +10.02% | Oct 29, 2025 |
| Wells Fargo | Wells Fargo | Buy Maintains $25 → $29 | Buy | Maintains | $25 → $29 | +13.95% | Oct 20, 2025 |
Financial Forecast
Revenue This Year
242.87M
from 258.00M
Decreased by -5.86%
Revenue Next Year
142.80M
from 242.87M
Decreased by -41.20%
EPS This Year
-3.71
from -3.14
EPS Next Year
-4.24
from -3.71
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 266.7M | 253.0M | ||||
| Avg | 242.9M | 142.8M | ||||
| Low | 224.4M | 36.3M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 3.4% | 4.2% | ||||
| Avg | -5.9% | -41.2% | ||||
| Low | -13.0% | -85.1% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -3.65 | -3.34 | ||||
| Avg | -3.71 | -4.24 | ||||
| Low | -3.76 | -5.12 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.